Ignite Creation Date:
2024-05-06 @ 7:53 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06176534
Status:
RECRUITING
Last Update Posted:
2023-12-19
First Post:
2023-12-09
Brief Title:
Combination Followed by Maintenance Chemotherapy Versus CDK46 Inhibitor Combined With Endocrine Therapy for HR LowHER2-negative Advanced Breast Cancer a Prospective Randomized Open-label Phase Ⅱ Clinical Trial
Sponsor:
Organization:
Henan Cancer Hospital